Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Vermeulen, Ruud C W ^a   Kurk, Ruud M ^a   Visser, Frans C ^a   Sluiter, Wim ^b   Scholte, Hans R ^b  

^a CFS and Pain Research Center Amsterdam   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE KINASE; GLUTAMIC ACID; LACTIC ACID; MALIC ACID; MALONIC ACID; PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUCCINIC ACID;

ADULT; ANAEROBIC GLYCOLYSIS; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYCLING; EXTERNAL OPHTHALMOPLEGIA; FEMALE; HUMAN; HUMAN CELL; MUSCLE MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; BIOSYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ELECTROCARDIOGRAPHY; EXERCISE; LUNG FUNCTION TEST; METABOLISM;

ADENOSINE TRIPHOSPHATE; ELECTROCARDIOGRAPHY; EXERCISE; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; RESPIRATORY FUNCTION TESTS;

EID: 77957679024     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-93     Document Type: Article

References (41)

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, Schluederberg A, Jones JF, Lloyd AR, Wessely S, . International Chronic Fatigue Syndrome Study Group The chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine 1994, 121:953-959. International Chronic Fatigue Syndrome Study Group.
2. Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Experimental and Molecular Pathology 2007, 83:84-92. 10.1016/j.yexmp.2006.09.008, 17239370.
3. Lane RJM, Barrett MC, Taylor DJ, Kemp GJ, Lodi R. Heterogeneity in chronic fatigue syndrome: Evidence from magnetic resonance spectroscopy of muscle. Neuromuscular Disorders 1998, 8:204-209. 10.1016/S0960-8966(98)00021-2, 9631403.
4. Barnes PRJ, Taylor DJ, Kemp GJ, Radda GK. Skeletal muscle bioenergetics in the chronic fatigue syndrome. Journal of Neurology Neurosurgery and Psychiatry 1993, 56:679-683.
5. Bains W. Treating Chronic Fatigue states as a disease of the regulation of energy metabolism. Medical Hypotheses 2008, 71:481-488. 10.1016/j.mehy.2008.02.022, 18684570.
6. Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. International Journal of Clinical and Experimental Medicine 2009, 2:1-16. 2680051, 19436827.
7. Chinnery PF, Turnbull DM. Mitochondrial medicine. QJM - Monthly Journal of the Association of Physicians 1997, 90:657-667.
8. Fulle S, Mecocci P, Fano G, Vecchiet I, Vecchini A, Racciotti D, Cherubini A, Pizzigallo E, Vecchiet L, Senin U, Beal MF. Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radical Biology and Medicine 2000, 29:1252-1259. 10.1016/S0891-5849(00)00419-6, 11118815.
9. Chaudhuri A, Behan PO. In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukotrienes and Essential Fatty Acids 2004, 71:181-183.
10. Jammes Y, Steinberg JG, Mambrini O, Bregeon F, Delliaux S. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. Journal of Internal Medicine 2005, 257:299-310. 10.1111/j.1365-2796.2005.01452.x, 15715687.
11. Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJF. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radical Biology and Medicine 2005, 39:584-589. 10.1016/j.freeradbiomed.2005.04.020, 16085177.
12. Agostoni P, Bianchi M, Moraschi A, Palermo P, Cattadori G, La Gioia R, Bussotti M, Wasserman K. Work-rate affects cardiopulmonary exercise test results in heart failure. European Journal of Heart Failure 2005, 7:498-504. 10.1016/j.ejheart.2004.06.007, 15921786.
13. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Principles of exercise testing and interpretation 2005, Philadelphia: Lippincott Williams & Wilkins, 4.
14. VanNess JM, Stevens SR, Bateman L, Stiles TL, Snell CR. Postextertional malaise in women with chronic fatigue syndrome. Journal of Women's Health 2010, 19:239-244. 10.1089/jwh.2009.1507, 20095909.
15. Nijs J, van Oosterwijck J, Meeus M, Lambrecht L, Metzger K, Frémont M, Paul L. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1β. Journal of Internal Medicine 2010, 267:418-435. 10.1111/j.1365-2796.2009.02178.x, 20433584.
16. Van Oosterwijck J, Nijs J, Meeus M, Lefever I, Huybrechts L, Lambrecht L, Paul L. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: An experimental study. Journal of Internal Medicine 2010, 268:265-278. 10.1111/j.1365-2796.2010.02228.x, 20412374.
17. Bogaard JM, Scholte HR, Busch HFM, Stam H, Versprille A. Anaerobic threshold as detected from ventilatory and metabolic exercise responses in patients with mitochondrial respiratory chain defect. Advances in Cardiology 1986, 35:135-145.
18. Wallace DC, Zheng X, Lott MT, Shoffner JM, Hodge JA, Kelley RI, Epstein CM, Hopkins LC. Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988, 55:601-610. 10.1016/0092-8674(88)90218-8, 3180221.
19. VanNess JM, Snell CR, Stevens SR. Diminished cardiopulmonary capacity during post-exertional malaise. Journal of Chronic Fatigue Syndrome 2008, 14:77-85.
20. Vermeulen RCW. Translation and validation of the Dutch language version of the CDC Symptom Inventory for assessment of Chronic Fatigue Syndrome (CFS). Population Health Metrics 2006, 4.
21. de Wit LEA, Sluiter W. Reliable assay for measuring complex I activity in human blood lymphocytes and skin fibroblasts. Methods in Enzymology 2009, 456:169-181. full_text, 19348888.
22. Korsten A, de Coo IFM, Spruijt L, de Wit LEA, Smeets HJM, Sluiter W. Patients with Leber hereditary optic neuropathy fail to compensate impaired oxidative phosphorylation. Biochimica Biophysica Acta 2010, 1797:197-203.
23. Srere PA. Citrate synthase. Methods in Enzymology 1969, 13:3-11.
24. Driessen-Kletter MF, Bar PR, Scholte HR, Hoogenraad TU, Luyt-Houwen IEM. A striking correlation between muscle damage after exercise and mitochondrial dysfunction in patients with chronic external ophthalmoplegia. Journal of Inherited Metabolic Disease 1987, 10(suppl 2):252-255.
25. Paul L, Wood L, Behan WMH, Maclaren WM. Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome. European Journal of Neurology 1999, 6:63-69. 10.1046/j.1468-1331.1999.610063.x, 10209352.
26. Kaiser J. Biomedicine. Genes and chronic fatigue: how strong is the evidence?. Science 2006, 312:669-671. 10.1126/science.312.5774.669, 16675668.
27. Witkowski JA. The postgenomic era and complex disease. Pharmacogenomics 2006, 7:341-343. 10.2217/14622416.7.3.341, 16610944.
28. Carmel L, Efroni S, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS. Gene expression profile of empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 2006, 7:375-386. 10.2217/14622416.7.3.375, 16610948.
29. Fang H, Xie Q, Boneva R, Fostel J, Perkins R, Tong W. Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics 2006, 7:429-440. 10.2217/14622416.7.3.429, 16610953.
30. Fostel J, Boneva R, Lloyd A. Exploration of the gene expression correlates of chronic unexplained fatigue using factor analyis. Pharmacogenomics 2006, 7:441-454. 10.2217/14622416.7.3.441, 16610954.
31. Goertzel BN, Pennachin C, de Souza Coelho L, Gurbaxani B, Maloney EM, Jones JF. Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics 2006, 7:475-483. 10.2217/14622416.7.3.475, 16610957.
32. Demitrack MA. Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: A commentary. Pharmacogenomics 2006, 7:521-528. 10.2217/14622416.7.3.521, 16610962.
33. Kaushik N, Fear D, Richards SCM, McDermott CR, Nuwaysir EF, Kellam P, Harrison TJ, Wilkinson RJ, Tyrrell DAJ, Holgate ST, Kerr JR. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. Journal of Clinical Pathology 2005, 58:826-832. 10.1136/jcp.2005.025718, 1770875, 16049284.
34. Gow JW, Hagan S, Herzyk P, Cannon C, Behan PO, Chaudhuri A. A gene signature for post-Infectious chronic fatigue syndrome. BMC Medical Genomics 2009, 2. 2672098, 19133145.
35. van Raam BJ, Sluiter W, de Wit LEA, Roos D, Verhoeven AJ, Kuijpers TW. Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation. PLoS ONE 2008, 3:e2013. 10.1371/journal.pone.0002013, 2295260, 18431494.
36. Maianski NA, Geissler J, Srinivasula SM, Alnemri ES, Roos D, Kuijpers TW. Functional characterization of mitochondria in neutrophils: A role restricted to apoptosis. Cell Death and Differentiation 2004, 11:143-153. 10.1038/sj.cdd.4401320, 14576767.
37. Mathew SJ, Mao X, Keegan KA, Levine SM, Smith ELP, Heier LA, Otcheretko V, Coplan JD, Shungu DC. Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: An in vivo 3.0 T 1H MRS imaging study. NMR in Biomedicine 2009, 22:251-258. 10.1002/nbm.1315, 18942064.
38. McCully KK, Natelson BH. Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clinical Science 1999, 97:603-608. 10.1042/CS19980372, 10545311.
39. Neary JP, Roberts ADW, Leavins N, Harrison MF, Croll JC, Sexsmith JR. Prefrontal cortex oxygenation during incremental exercise in chronic fatigue syndrome. Clinical Physiology and Functional Imaging 2008, 28:364-372. 10.1111/j.1475-097X.2008.00822.x, 18671793.
40. Streeten DHP, Bell DS. Circulating blood volume in chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome 1998, 4:3-11.
41. Hurwitz BE, Coryell VT, Parker M, Martin P, Laperriere A, Klimas NG, Sfakianakis GN, Bilsker MS. Chronic fatigue syndrome: Illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clinical Science 2010, 118:125-135.